Regulations.gov document
New and Revised Draft Q&As on Biosimilar Development and the Biologics Price Competition…
Notice · FDA-2011-D-0611 · posted Dec 12, 2018
Key facts
| Document ID | FDA-2011-D-0611-0065 |
|---|---|
| Title | New and Revised Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act (Revision 2); Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2011-D-0611 |
| Posted | Dec 12, 2018 |
| Federal Register citation | 83 FR 63898 |
| FR document number | 2018-26852 |
| Comment period opens | Dec 12, 2018 |
| Comments due | Feb 12, 2019 |
| Effective date | Dec 12, 2018 |
At a glance
- 1–9 Pages
- No Open for comment
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: